Angioedema and photosensitive rash induced by valsartan

Pharmacotherapy

Volumn 18, Issue 4, 1998, Pages 866-868

  Frye, Caria B ^a   Pettigrew, Timothy J ^b  

^a BUTLER UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; LANOLIN ALCOHOL; LOSARTAN; METHYLPREDNISOLONE; VALSARTAN;

AGED; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE TIME EFFECT RELATION; DRUG SAFETY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; RASH; RISK ASSESSMENT;

AGED; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE AGENTS; DERMATOMYOSITIS; FEMALE; HUMANS; PHOTOSENSITIVITY DISORDERS; PRURITUS; SKIN; TETRAZOLES; VALINE;

EID: 0031854792     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Austin KF. Disorders of immune-mediated injury. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994:2634-6.
2. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting enzyme inhibitors. JAMA 1988;260:967-70.
3. Rees RS, Bergman J, Ramirez-Alexander R. Angioedema associated with lisinopril. Am J Emerg Med 1992;10:321-2.
4. Weber MA. Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors. Am J Med 1988;84(suppl 4A):16-23.
5. Novartis Pharmaceuticals Corp. Diovan (valsartan) package insert. Summit, NJ; 1996.
6. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997;90:552-3.
7. Acker CG, Greenberg A. Angioedema induced the by the angiotensin II blocker losartan [letter]. N Engl J Med 1995;333:1572.
8. Carr AA, Prisant LM. Losartan: first of a new class of angiotensin antagonists for the management of hypertension. J Clin Pharmacol 1996;36:3-12.
9. Pitt B, Chang P, Timmermans PB. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial. Cardiovasc Drugs Ther 1995;9:693-700.
10. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992;117:234-42.
11. O'Mara NB, O'Mara EM Jr. Delayed onset of angioedema with angiotensin-converting enzyme inhibitors: case report and review of the literature. Pharmacotherapy 1996;16:675-9.
12. Verresen L, Fink E, Lemke H-D, Vanrenterghem Y. Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 1994;45: 1497-503.
13. Lacourcière Y, Lefebvre J, Nakhle G, Faison EP, Snavely DB, Nelson EB. Association between cough and angiotensin converting inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. J Hypertens 1994;12(suppl 2):S49-53.
14. Australian Adverse Drug Reactions Advisory Committee. Angioedema and ACE inhibitors. Australian Adverse Drug Reactions Bull 1996; 15:15.
15. Wilken JK, Hammond JJ, Kirkendall WM. The captoprilinduced eruption - a possible mechanism: cutaneous kinin potentiation. Arch Dermatol 1980;116:902-5.